Reduced ATPase ASNA1 expression was associated with the significant inhibition of cell growth, increased apoptosis and increased sensitivity to cisplatin and arsenite in human melanoma cells [54] and increased sensitivity to cisplatin, carboplatin, oxaliplatin and arsenite in human ovarian cancer cells [55]. This evidence concerns the gene GET3 and ovarian cancer.